Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis

키워드

참고문헌 (64)

1. Farrell B, "Deprescribing proton pump inhibitors: evidence-based clinical practice guideline", Can Fam Physician, 63, pp.354~364 (2017)
2. Lanza FL, "Guidelines for prevention of NSAID-related ulcer complications", Am J Gastroenterol, 104, pp.728~738 (2009)[DOI]
3. Wolfe MM, "The physiology of gastric acid secretion", N Engl J Med, 319, pp.1707~1715 (1988)[DOI]
4. Eusebi LH, "Proton pump inhibitors: risks of long-term use", J Gastroenterol Hepatol, 32, pp.1295~1302 (2017)[DOI]
5. Richards JB, "Proton pump inhibitors: balancing the benefits and potential fracture risks", CMAJ, 179, pp.306~307 (2008)[DOI]
6. Laine L, "Proton pump inhibitors and bone fractures", Am J Gastroenterol, 104(Suppl 2), pp.S21~S26 (2009)[DOI]
7. Zhou B, "Proton-pump inhibitors and risk of fractures: an update meta-analysis", Osteoporos Int, 27, pp.339~347 (2016)[DOI]
8. Abrahamsen B, "Proton pump inhibitor use and the antifracture efficacy of alendronate", Arch Intern Med, 171, pp.998~1004 (2011)
9. Abrahamsen B, "Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data", Bone, 57, pp.269~271 (2013)[DOI]
10. Adams AL, "Proton-pump inhibitor use and hip fractures in men: a population-based case-control study", Ann Epidemiol, 24, pp.286~290 (2014)[DOI]
11. Arj A, "Proton pump inhibitors use and change in bone mineral density", Int J Rheum Dis, 19, pp.864~868 (2016)[DOI]
12. Bahtiri E, "Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors", J Bone Miner Metab, 34, pp.571~579 (2016)[DOI]
13. Chiu HF, "Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study", Pharmacoepidemiol Drug Saf, 19, pp.1131~1136 (2010)[DOI]
14. Corley DA, "Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients", Gastroenterology, 139, pp.93~101 (2010)[DOI]
15. Ding J, "The relationship between proton pump inhibitor adherence and fracture risk in the elderly", Calcif Tissue Int, 94, pp.597~607 (2014)[DOI]
16. Fraser LA, "The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study", Osteoporos Int, 24, pp.1161~1168 (2013)[DOI]
17. Freedberg DE, "Use of proton pump inhibitors is associated with fractures in young adults: a population-based study", Osteoporos Int, 26, pp.2501~2507 (2015)[DOI]
18. Gray SL, "Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative", Arch Intern Med, 170, pp.765~771 (2010)[DOI]
19. Kaye JA, "Proton pump inhibitor use and risk of hip fractures in patients without major risk factors", Pharmacotherapy, 28, pp.951~959 (2008)[DOI]
20. Khalili H, "Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study", BMJ, 344, pp.e372~ (2012)[DOI]
21. Kumar S, "Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study", Aliment Pharmacol Ther, 46, pp.1094~1102 (2017)[DOI]
22. Lee J, "A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate", J Gastroenterol, 48, pp.1016~1022 (2013)[DOI]
23. Lenihan CR, "Proton pump inhibitor use and risk of hip fracture in kidney transplant recipients", Am J Kidney Dis, 69, pp.595~601 (2017)[DOI]
24. Lewis JR, "Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study", J Bone Miner Res, 29, pp.2489~2497 (2014)[DOI]
25. Lin SM, "Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study", Osteoporos Int, 29, pp.153~162 (2018)[DOI]
26. Maggio M, "Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals", Bone, 57, pp.437~442 (2013)[DOI]
27. Moberg LM, "Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study", Maturitas, 78, pp.310~315 (2014)[DOI]
28. Ozdil K, "Bone density in proton pump inhibitors users: a prospective study", Rheumatol Int, 33, pp.2255~2260 (2013)[DOI]
29. Pouwels S, "Use of proton pump inhibitors and risk of hip", femur fracture: a population-based case-control study, 2011, pp.22, 903~910
30. Reyes C, "Use of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean region", Bone, 52, pp.557~561 (2013)[DOI]
31. Roux C, "Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors", Osteoporos Int, 23, pp.277~284 (2012)[DOI]
32. Solomon DH, "Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study", J Bone Miner Res, 30, pp.232~239 (2015)[DOI]
33. Targownik LE, "Use of proton pump inhibitors and risk of osteoporosis-related fractures", CMAJ, 179, pp.319~326 (2008)[DOI]
34. Targownik LE, "Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss", Gastroenterology, 138, pp.896~904 (2010)[DOI]
35. from the Canadian Multicentre Osteoporosis Study (CaMos), "Am J Gastroenterol", 2012, 1361~1369, 10.1038[DOI]
36. Targownik LE, "Long-term proton pump inhibitor use is not associated with changes in bone strength and structure", Am J Gastroenterol, 112, pp.95~101 (2017)[DOI]
37. van der Hoorn MMC, "The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: a prospective cohort study", Bone, 81, pp.675~682 (2015)[DOI]
38. Vestergaard P, "Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture", Calcif Tissue Int, 79, pp.76~83 (2006)[DOI]
39. Yang YX, "Long-term proton pump inhibitor therapy and risk of hip fracture", JAMA, 296, pp.2947~2953 (2006)[DOI]
40. Zirk-Sadowski J, "Proton-pump inhibitors and fragility fractures in vulnerable older patients", Am J Gastroenterol, 112, pp.520~523 (2017)[DOI]
41. Abraham NS, "Proton pump inhibitors: potential adverse effects", Curr Opin Gastroenterol, 28, pp.615~620 (2012)[DOI]
42. de la Coba Ortiz C, "Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Espanola de Patologia Digestiva", Rev Esp Enferm Dig, 108, pp.207~224 (2016)[DOI]
43. Heidelbaugh JJ, "Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications", Ther Adv Drug Saf, 4, pp.125~133 (2013)[DOI]
44. Li T, "The association of proton pump inhibitors and chronic kidney disease: cause or confounding", Curr Opin Nephrol Hypertens, 27, pp.182~187 (2018)
45. Costa-Rodrigues J, "Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity", Febs j, 280, pp.5052~5064 (2013)[DOI]
46. Sheraly AR, "Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo", Curr Drug Deliv, 6, pp.192~198 (2009)[DOI]
47. Sugiyama T, "Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?", Osteoporos Int, 27, pp.1675~1676 (2016)[DOI]
48. Gage BF, "Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2", Arch Intern Med, 166, pp.241~246 (2006)[DOI]
49. Turner MR, "Levothyroxine dose and risk of fractures in older adults: nested case-control study", BMJ, 342, pp.d2238~ (2011)[DOI]
50. Marks R, "Hip fractures among the elderly: causes, consequences and control", Ageing Res Rev, 2, pp.57~93 (2003)[DOI]
51. Tolppanen AM, "Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study", BMC Geriatr, 16, pp.204~ (2016)[DOI]
52. Shiraev TP, "Proton pump inhibitors and cardiovascular events: a systematic review", Heart Lung Circ, 27, pp.443~450 (2018)[DOI]
53. Ho PM, "Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome", JAMA, 301, pp.937~944 (2009)[DOI]
54. Bhatt DL, "Clopidogrel with or without omeprazole in coronary artery disease", N Engl J Med, 363, pp.1909~1917 (2010)[DOI]
55. Malhotra K, "Cerebrovascular outcomes with proton pump inhibitors and thienopyridines: a systematic review and meta-analysis", Stroke, 49, pp.312~318 (2018)[DOI]
56. Sukhovershin RA, "How may proton pump inhibitors impair cardiovascular health?", Am J Cardiovasc Drugs, 16, pp.153~161 (2016)[DOI]
57. Menzies IB, "The impact of comorbidity on perioperative outcomes of hip fractures in a geriatric fracture model", Geriatr Orthop Surg Rehabil, 3, pp.129~134 (2012)[DOI]
58. Roche JJ, "Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study", BMJ, 331, pp.1374~ (2005)[DOI]
59. Chiang CH, "Hip fracture and risk of acute myocardial infarction: a nationwide study", J Bone Miner Res, 28, pp.404~411 (2013)[DOI]
60. Dharmarajan TS, "Risk factors, preoperative assessment, and postoperative management", Postgrad Med, 119, pp.31~38 (2006)[DOI]
61. Durand C, "Proton pump inhibitor use in hospitalized patients: is overutilization becoming a problem", Clin Med Insights Gastroenterol, 5, pp.65~76 (2012)
62. Ngamruengphong S, "Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies", Am J Gastroenterol, 106, pp.1209~1218 (2011)[DOI]
63. McGowan B, "Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice", Pharmacoepidemiol Drug Saf, 19, pp.763~769 (2010)[DOI]
64. Fournier MR, "Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures", Maturitas, 64, pp.9~13 (2009)[DOI]

관련 논문AI추천